Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,590 | -26,249 | -85,466 | -34,608 | -42,914 |
| Depreciation Amortization | 5,992 | 5,726 | 4,082 | 4,070 | 2,982 |
| Income taxes - deferred | -5,163 | -5,501 | 1,889 | N/A | N/A |
| Accounts receivable | -1,856 | 843 | -1,194 | -3,220 | 243 |
| Accounts payable and accrued liabilities | 9,901 | -1,238 | -264 | 2,088 | 1,025 |
| Other Working Capital | -50,412 | 63,900 | 252,151 | -2,655 | 16,757 |
| Other Operating Activity | 16,983 | 28,010 | 25,321 | 9,695 | 5,422 |
| Operating Cash Flow | $-72,145 | $65,491 | $196,519 | $-24,630 | $-16,485 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,231 | 28,800 | -261,140 | -25,060 | -38,471 |
| PPE Investments | -4,949 | -10,764 | -5,446 | -4,986 | -1,947 |
| Purchase Of Investment | -10,000 | -100 | -10,000 | N/A | N/A |
| Other Investing Activity | 6,151 | 0 | -839 | 0 | 0 |
| Investing Cash Flow | $14,433 | $17,936 | $-277,425 | $-30,046 | $-40,418 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 957 | 4,000 | 1,037 |
| Debt Repayment | N/A | -6,758 | -3,333 | -2,259 | -843 |
| Common Stock Issued | 3,509 | 9,913 | 61,011 | 164,890 | 52,423 |
| Financing Cash Flow | $3,509 | $3,155 | $58,635 | $166,631 | $52,617 |
| Exchange Rate Effect | -121 | 53 | -527 | 243 | -229 |
| Beginning Cash Position | 191,792 | 105,157 | 127,955 | 15,757 | 20,272 |
| End Cash Position | 137,468 | 191,792 | 105,157 | 127,955 | 15,757 |
| Net Cash Flow | $-54,324 | $86,635 | $-22,798 | $112,198 | $-4,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,145 | 65,491 | 196,519 | -24,630 | -16,485 |
| Capital Expenditure | -4,949 | -10,764 | -7,788 | -4,986 | -1,947 |
| Free Cash Flow | -77,094 | 54,727 | 188,731 | -29,616 | -18,432 |